Health

US hospital adverse events drop significantly

The largest medical record-based study ever of adverse events suffered by hospitalized patients in the U.S., published in the July 12 issue of JAMA, reports a significant decrease in the rate of adverse events over the last ...

Medications

Empagliflozin offers clinical benefit in heart failure

For patients hospitalized for acute heart failure, treatment with the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin produces clinical benefit, according to a study published online April 4 in Circulation ...

Medical research

Exploring the recovery process after a heart attack

A recent study published in the journal Molecular Therapy - Nucleic Acids on the harmful effects of acute myocardial infarction opens the door to the administration of a molecule (urocortin-2) as a potential treatment to ...

page 1 from 22